|
|
[ 0.00, 0.67 ) |
0.00 mg/100 ml
|
Sunkist Lot 3 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
0.00 mg/100 ml
|
Dole 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
0.00 mg/100 ml
|
Rio Red Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
0.00 mg/100 ml
|
Rio Red Lot 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
0.22 mg/100 ml
|
Sunkist Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
|
[ 0.67, 1.34 ) |
1.02 mg/100 ml
|
New Zealand Lot 1 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
|
[ 1.34, 2.01 ) |
1.60 mg/100 ml
|
New Zealand Lot 5 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
|
[ 2.01, 2.68 ) |
2.20 mg/100 ml
|
New Zealand Lot 2 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
|
[ 3.35, 4.02 ) |
3.90 mg/100 ml
|
New Zealand Lot 6 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |
|
|
[ 6.03, 6.71 ) |
6.70 mg/100 ml
|
New Zealand Lot 4 |
Ho P.C., et al (2000) Content of CYP3A4 inhibitors, naringin, .... Pharmaceutica Acta Helvetiae 74:379-385 PubMed (10812937) |